Literature DB >> 34162359

Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.

Yutaka Miyawaki1, Hiroshi Sato2, Shuichiro Oya2, Hirofumi Sugita2, Yasumitsu Hirano2, Shinichi Sakuramoto2, Kojun Okamotom2, Shigeki Yamaguchim2, Isamu Koyama2.   

Abstract

BACKGROUND: Surgery is still the mainstay of radical treatment for resectable esophageal cancer (EC). It is apparent that the presence or spread of lymph node metastasis (LNM) is a powerful prognostic factor in patients with EC who are eligible for curative treatment. Although the importance and efficacy of lymph node dissection in radical esophagectomy have been reported, the clinical or prognostic relevance of specific metastatic patterns within the mediastinal cavity and abdomen remains unclear.
METHODS: We retrospectively analyzed the association of postoperative survival with clinical mediastinal LNM (cMLNM) and abdominal LNM (cALNM) in 157 patients who underwent radical EC surgery at our hospital between May 2012 and March 2018.
RESULTS: A significant difference in cause-specific survival (CSS) was observed between patients with and without cALNM (log-rank p = 0.000). A multivariate Cox regression analysis revealed that cALNM and thoracic surgery (mediastinal lymphadenectomy via conventional open right thoracotomy or video-assisted thoracoscopic surgery) independently predicted CSS (p = 0.0007 and 0.021, respectively). Moreover, a significant difference in systemic recurrence-free survival was observed between those with and without cALNM (log-rank p = 0.000). Multivariate Cox regression analysis revealed that cALNM and sex independently predicted systemic recurrence-free survival (p = 0.000 and 0.015, respectively).
CONCLUSION: cALNM was an independent poor prognostic factor for CSS after EC surgery. It may also be an independent prognostic factor for postoperative systemic recurrence, which can shorten the CSS. For patients with cALNM-positive EC who have a high potential risk of systemic metastases, more extensive treatment besides the conventional perioperative systemic chemotherapy may be necessary.

Entities:  

Keywords:  Abdominal lymph node metastasis; Esophageal cancer; Survival

Year:  2021        PMID: 34162359     DOI: 10.1186/s12885-021-08484-2

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  24 in total

1.  The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer.

Authors:  Harushi Udagawa; Masaki Ueno; Hisashi Shinohara; Shusuke Haruta; Sachiko Kaida; Masatoshi Nakagawa; Masahiko Tsurumaru
Journal:  J Surg Oncol       Date:  2012-04-13       Impact factor: 3.454

2.  Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Shuji Takiguchi; Kiyokazu Nakajima; Yoshiyuki Fujiwara; Koji Konishi; Masaki Mori; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

3.  Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Thomas W Rice; Donna M Gress; Deepa T Patil; Wayne L Hofstetter; David P Kelsen; Eugene H Blackstone
Journal:  CA Cancer J Clin       Date:  2017-05-26       Impact factor: 508.702

4.  Sterilization of tumor-positive lymph nodes of esophageal cancer by neo-adjuvant treatment is associated with worse survival compared to tumor-negative lymph nodes treated with surgery first.

Authors:  Styliani Mantziari; Pierre Allemann; Michael Winiker; Christine Sempoux; Nicolas Demartines; Markus Schäfer
Journal:  J Surg Oncol       Date:  2017-05-25       Impact factor: 3.454

Review 5.  Oesophageal cancer.

Authors:  Jesper Lagergren; Elizabeth Smyth; David Cunningham; Pernilla Lagergren
Journal:  Lancet       Date:  2017-06-22       Impact factor: 79.321

6.  Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.

Authors:  Alexander W Phillips; Sjoerd M Lagarde; Maziar Navidi; Babbet Disep; S Michael Griffin
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

7.  The Prevalence of Overall and Initial Lymph Node Metastases in Clinical T1N0 Thoracic Esophageal Cancer: From the Results of JCOG0502, a Prospective Multicenter Study.

Authors:  Yasunori Akutsu; Ken Kato; Hiroyasu Igaki; Yoshinori Ito; Isao Nozaki; Hiroyuki Daiko; Masahiko Yano; Harushi Udagawa; Satoru Nakagawa; Masakazu Takagi; Junki Mizusawa; Yuko Kitagawa
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

8.  Total number of resected lymph nodes predicts survival in esophageal cancer.

Authors:  Nasser K Altorki; Xi Kathy Zhou; Brendon Stiles; Jeffrey L Port; Subroto Paul; Paul C Lee; Madhu Mazumdar
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

9.  Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.

Authors:  Yuko Kitagawa; Takashi Uno; Tsuneo Oyama; Ken Kato; Hiroyuki Kato; Hirofumi Kawakubo; Osamu Kawamura; Motoyasu Kusano; Hiroyuki Kuwano; Hiroya Takeuchi; Yasushi Toh; Yuichiro Doki; Yoshio Naomoto; Kenji Nemoto; Eisuke Booka; Hisahiro Matsubara; Tatsuya Miyazaki; Manabu Muto; Akio Yanagisawa; Masahiro Yoshida
Journal:  Esophagus       Date:  2018-08-31       Impact factor: 3.671

10.  Verification of oncological local control for hand-assisted laparoscopic abdominal lymph node dissection in esophageal cancer surgery: a propensity score-matched analysis.

Authors:  Yutaka Miyawaki; Hiroshi Sato; Naoto Fujiwara; Junya Aoyama; Shuichiro Oya; Hirofumi Sugita; Yasumitsu Hirano; Shinichi Sakuramoto; Kojun Okamoto; Shigeki Yamaguchi; Isamu Koyama
Journal:  Esophagus       Date:  2020-07-30       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.